Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review

March 2021 | 93 pages | ID: B9BD9859156EN
GlobalData

Abstracts

Bayer AG (BAYN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bayer AG (Bayer) discovers, develops, manufactures, and commercializes products for human health care, and agriculture. It provides medicines for cardiovascular diseases, women’s health, cancer, hematology, ophthalmology and other indications. The company's product portfolio includes prescription products, specialty pharmaceuticals, diagnostic imaging equipment, nonprescription (over-the-counter or OTC) products, seeds, crop protection solutions and non-agricultural pest control solutions. Bayer markets its healthcare and crop protection products essentially through wholesalers, pharmacies, hospitals and retailers. It operates through a network of subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa and the Middle East. Bayer is headquartered in Leverkusen, Germany.

Bayer AG Key Recent Developments

Mar 12,2021: March 12, 2021 Elections at the Annual Stockholders'' Meeting on April 27, 2021:Bayer to further strengthen expertise and international profile of its Supervisory BoardRead more
Mar 12,2021: Bayer to further strengthen expertise and international profile of its Supervisory Board
Mar 10,2021: Bayer expects dynamic growth with higher profitability in the coming years and is accelerating its transformation
Feb 25,2021: Bayer reports steady 2020 performance despite Covid-19 pandemic
Feb 25,2021: Bayer delivers robust performance despite pandemic – foundation laid for future growth

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Bayer AG - Key Facts
Bayer AG - Key Employees
Bayer AG - Key Employee Biographies
Bayer AG - Major Products and Services
Bayer AG - History
Bayer AG - Company Statement
Bayer AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Bayer AG - Business Description
Business Segment: All Other Segments
Overview
Performance
Business Segment: Consumer Health
Overview
Performance
Key Stats
Business Segment: Crop Science
Overview
Performance
Key Stats
Business Segment: Enabling Functions & Consolidation
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Key Stats
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Bayer AG - Corporate Strategy
Bayer AG - SWOT Analysis
SWOT Analysis - Overview
Bayer AG - Strengths
Bayer AG - Weaknesses
Bayer AG - Opportunities
Bayer AG - Threats
Bayer AG - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES, POWER FINANCIAL DEALS AND ALLIANCES

Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bayer AG, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 12, 2021: March 12, 2021 Elections at the Annual Stockholders'' Meeting on April 27, 2021:Bayer to further strengthen expertise and international profile of its Supervisory BoardRead more
Mar 12, 2021: Bayer to further strengthen expertise and international profile of its Supervisory Board
Mar 10, 2021: Bayer expects dynamic growth with higher profitability in the coming years and is accelerating its transformation
Feb 25, 2021: Bayer reports steady 2020 performance despite Covid-19 pandemic
Feb 25, 2021: Bayer delivers robust performance despite pandemic – foundation laid for future growth
Feb 17, 2021: Otto Bayer Award goes to Prof. Ruth Ley PhD
Feb 17, 2021: PeptiDream announces achievement of development milestone in discovery alliance with Bayer
Feb 16, 2021: Dare Bioscience to participate at the Women’s Health Innovation Series: Contraception Innovation Summit to be held Virtually on February 23, 2021
Feb 04, 2021: National Kidney Foundation and award-winning actress Debbie Allen partner with Bayer to launch new joint initiative to educate on the increased risk of chronic kidney disease in people with Type 2 diabetes
Feb 03, 2021: Bayer announces agreement with plaintiffs’ counsel on class plan

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Bayer AG, Key Facts
Bayer AG, Key Employees
Bayer AG, Key Employee Biographies
Bayer AG, Major Products and Services
Bayer AG, History
Bayer AG, Subsidiaries
Bayer AG, Joint Venture
Bayer AG, Key Competitors
Bayer AG, Ratios based on current share price
Bayer AG, Annual Ratios
Bayer AG, Annual Ratios (Cont...1)
Bayer AG, Annual Ratios (Cont...2)
Bayer AG, Interim Ratios
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bayer AG, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bayer AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Bayer AG, Performance Chart (2016 - 2020)
Bayer AG, Ratio Charts
Bayer AG, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bayer AG, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021